Spire Wealth Management Arrowhead Pharmaceuticals, Inc. Transaction History

Spire Wealth Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 18, 2022	SELL	$39.62 - $69.97 $4,001 - $7,066	-101 Closed	0 $0
Q4 2021 Jan 14, 2022	BUY	$58.09 - $82.51 $5,867 - $8,333	101 New	101 $7,000
Q2 2021 Jul 26, 2021	SELL	$62.15 - $90.32 $6,277 - $9,122	-101 Closed	0 $0
Q1 2021 May 21, 2021	BUY	$61.35 - $90.47 $6,196 - $9,137	101 New	101 $6,000

294

90.8M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.01B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.